Literature DB >> 12704116

Chondroitin sulfate proteoglycan expression and binding of Plasmodium falciparum-infected erythrocytes in the human placenta during pregnancy.

Sean T Agbor-Enoh1, Rajeshwara N Achur, Manojkumar Valiyaveettil, Rose Leke, Diane W Taylor, D Channe Gowda.   

Abstract

A characteristic feature of malaria during pregnancy is the sequestration of Plasmodium falciparum-infected red blood cells (IRBCs) in the intervillous spaces of the placenta. We have recently shown that unusually low-sulfated chondroitin sulfate proteoglycans (CSPGs) present in the intervillous spaces mediate the adherence of IRBCs in the placenta. In areas of endemicity, the prevalence of P. falciparum infection in pregnant women peaks during weeks 13 to 20 and then gradually declines, implying that the placental CSPGs are available for IRBC adhesion early during the pregnancy. However, there is no information on the expression and composition of CSPGs during pregnancy. In this study, the expression pattern of CSPGs during the course of pregnancy was investigated. The CSPGs were purified from placentas of various gestational ages, characterized, and tested for the ability to bind IRBCs. The data demonstrate that the CSPGs are present in the intervillous spaces throughout the second and third trimesters. The levels of CSPGs expressed per unit tissue weight were similar in placentas of various gestational ages. However, the structures of the intervillous-space CSPGs changed considerably during the course of pregnancy. In particular, the molecular weight was decreased, with an accompanying gradual increase in the CSPG size polydispersity, from 16 weeks until 38 weeks. The sulfate content was increased considerably after 24 weeks. Despite these structural changes, the CSPGs of placentas of various gestational ages efficiently supported the binding of IRBCs. These results demonstrate that CSPGs can mediate the sequestration of IRBCs in the intervillous spaces of the placenta during the entire second and third trimesters and possibly during the later part of the first trimester as well.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12704116      PMCID: PMC153269          DOI: 10.1128/IAI.71.5.2455-2461.2003

Source DB:  PubMed          Journal:  Infect Immun        ISSN: 0019-9567            Impact factor:   3.441


  43 in total

1.  Motherhood and malaria.

Authors:  L H Miller; J D Smith
Journal:  Nat Med       Date:  1998-11       Impact factor: 53.440

2.  Colorimetric determination of hyaluronate degraded by Streptomyces hyaluronidase.

Authors:  Y Hatae; A Makita
Journal:  Anal Biochem       Date:  1975-03       Impact factor: 3.365

3.  An analysis of malaria in pregnancy in Africa.

Authors:  B J Brabin
Journal:  Bull World Health Organ       Date:  1983       Impact factor: 9.408

4.  Plasmodium falciparum associated placental pathology: a light and electron microscopic and immunohistologic study.

Authors:  M Yamada; R Steketee; C Abramowsky; M Kida; J Wirima; D Heymann; J Rabbege; J Breman; M Aikawa
Journal:  Am J Trop Med Hyg       Date:  1989-08       Impact factor: 2.345

Review 5.  Parasite adhesion and immune evasion in placental malaria.

Authors:  J G Beeson; J C Reeder; S J Rogerson; G V Brown
Journal:  Trends Parasitol       Date:  2001-07

6.  Gravidity-dependent production of antibodies that inhibit binding of Plasmodium falciparum-infected erythrocytes to placental chondroitin sulfate proteoglycan during pregnancy.

Authors:  I O'Neil-Dunne; R N Achur; S T Agbor-Enoh; M Valiyaveettil; R S Naik; C F Ockenhouse; A Zhou; R Megnekou; R Leke; D W Taylor; D C Gowda
Journal:  Infect Immun       Date:  2001-12       Impact factor: 3.441

Review 7.  Malaria in 2002.

Authors:  Brian Greenwood; Theonest Mutabingwa
Journal:  Nature       Date:  2002-02-07       Impact factor: 49.962

8.  Prevalence of Plasmodium falciparum infection in pregnant Cameroonian women.

Authors:  Ainong Zhou; Rosette Megnekou; Robert Leke; Josephine Fogako; Simon Metenou; Bruce Trock; Diane W Taylor; Rose F G Leke
Journal:  Am J Trop Med Hyg       Date:  2002-12       Impact factor: 2.345

9.  Malaria infection of the placenta in The Gambia, West Africa; its incidence and relationship to stillbirth, birthweight and placental weight.

Authors:  I A McGregor; M E Wilson; W Z Billewicz
Journal:  Trans R Soc Trop Med Hyg       Date:  1983       Impact factor: 2.184

10.  Adherence of Plasmodium falciparum to chondroitin sulfate A in the human placenta.

Authors:  M Fried; P E Duffy
Journal:  Science       Date:  1996-06-07       Impact factor: 47.728

View more
  15 in total

1.  Chondroitin sulfate proteoglycan but not hyaluronic acid is the receptor for the adherence of Plasmodium falciparum-infected erythrocytes in human placenta, and infected red blood cell adherence up-regulates the receptor expression.

Authors:  Arivalagan Muthusamy; Rajeshwara N Achur; Manojkumar Valiyaveettil; John J Botti; Diane W Taylor; Rose F Leke; D Channe Gowda
Journal:  Am J Pathol       Date:  2007-06       Impact factor: 4.307

2.  High levels of antibodies to multiple domains and strains of VAR2CSA correlate with the absence of placental malaria in Cameroonian women living in an area of high Plasmodium falciparum transmission.

Authors:  Yeung L Tutterrow; Marion Avril; Kavita Singh; Carole A Long; Robert J Leke; Grace Sama; Ali Salanti; Joseph D Smith; Rose G F Leke; Diane W Taylor
Journal:  Infect Immun       Date:  2012-02-13       Impact factor: 3.441

3.  Rapid acquisition of isolate-specific antibodies to chondroitin sulfate A-adherent plasmodium falciparum isolates in Ghanaian primigravidae.

Authors:  Sharon E Cox; Trine Staalsoe; Paul Arthur; Judith N Bulmer; Lars Hviid; Kojo Yeboah-Antwi; Betty R Kirkwood; Eleanor M Riley
Journal:  Infect Immun       Date:  2005-05       Impact factor: 3.441

4.  Novel inhibitor of Plasmodium histone deacetylase that cures P. berghei-infected mice.

Authors:  S Agbor-Enoh; C Seudieu; E Davidson; A Dritschilo; M Jung
Journal:  Antimicrob Agents Chemother       Date:  2009-02-17       Impact factor: 5.191

5.  Plasmodium falciparum: Assessment of parasite-infected red blood cell binding to placental chondroitin proteoglycan and bovine tracheal chondroitin sulfate A.

Authors:  Atul Goyal; Suchi Goel; D Channe Gowda
Journal:  Exp Parasitol       Date:  2009-06-07       Impact factor: 2.011

6.  Structural basis for placental malaria mediated by Plasmodium falciparum VAR2CSA.

Authors:  Rui Ma; Tengfei Lian; Rick Huang; Jonathan P Renn; Jennifer D Petersen; Joshua Zimmerberg; Patrick E Duffy; Niraj H Tolia
Journal:  Nat Microbiol       Date:  2021-01-15       Impact factor: 17.745

7.  Clinical development of placental malaria vaccines and immunoassays harmonization: a workshop report.

Authors:  Arnaud Chêne; Sophie Houard; Morten A Nielsen; Sophia Hundt; Flavia D'Alessio; Sodiomon B Sirima; Adrian J F Luty; Patrick Duffy; Odile Leroy; Benoit Gamain; Nicola K Viebig
Journal:  Malar J       Date:  2016-09-17       Impact factor: 2.979

8.  Soluble Tumor Necrosis Factor-α Receptor 2 in Urine Is a Potential Biomarker for Noninvasive Diagnosis of Malaria During Pregnancy.

Authors:  Samuel Tassi Yunga; Audrey Davidson Thévenon; Rose Gana Fomban Leke; Diane Wallace Taylor
Journal:  Open Forum Infect Dis       Date:  2016-04-26       Impact factor: 3.835

9.  Malaria in pregnancy.

Authors:  Ebako Ndip Takem; Umberto D'Alessandro
Journal:  Mediterr J Hematol Infect Dis       Date:  2013-01-02       Impact factor: 2.576

Review 10.  The role of infection in miscarriage.

Authors:  Sevi Giakoumelou; Nick Wheelhouse; Kate Cuschieri; Gary Entrican; Sarah E M Howie; Andrew W Horne
Journal:  Hum Reprod Update       Date:  2015-09-19       Impact factor: 15.610

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.